FindTrial
Sign In

Clinical and pathological study of ovarian serous carcinoma

Clinical and pathological study of ovarian serous carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15006925
Enrollment
Unknown
Registered
2015-08-13
Start date
2015-08-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian serous carcinoma

Interventions

TK1 group :TK1
Ki-67 group :Ki-67

Sponsors

Department of Pathology, Jinling Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. patients aged 18-70; 2. female; 3. more than 2 months expected survival; 4. Non radiotherapy or non irradiation pain site.

Exclusion criteria

Exclusion criteria: 1. lacking of clinial information; 2. without other malignant tumors.

Design outcomes

Primary

MeasureTime frame
TK1;Ki-67;Survival time and state;Recurrence time and state;clinical stages;tumor size;Chemotherapy regimen;—

Secondary

MeasureTime frame
WHO grade;Age;tumor site;—

Countries

China

Contacts

Public ContactShi qunli
shiqunli2005@aliyun.com+86 13815875431

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026